Status:
COMPLETED
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
Lead Sponsor:
Genentech, Inc.
Conditions:
Lymphoma, Non Hodgkin
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by ...
Eligibility Criteria
Inclusion
- Signed Informed Consent Form (unless the Institutional Review Board \[IRB\] has granted a waiver of consent)
- Signed Authorization for the Use and Disclosure of Health Information document
- Age ≥18 years
- Histologic documentation of follicular NHL, according to Revised European-American Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician
- Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
- Availability of cancer-specific historical data points in the patient's medical records
Exclusion
- Other indolent or histologic NHL subtypes
- Diagnosis of lymphoma \> 6 months prior to enrollment
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
2740 Patients enrolled
Trial Details
Trial ID
NCT00097565
Start Date
March 1 2004
End Date
March 1 2014
Last Update
March 23 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.